Serge Saxonov, Chief Executive Officer at 10x Genomics, Inc. (TXG), sold 18,902 shares at $22.67 ($367K) on 2026-03-02, disclosed to the SEC on 2026-03-04.
Scheduled sale ($367k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.67 | 14,292 | $324K | 88.3% |
| 2 | $23.18 | 1,860 | $43K | 11.7% |
| 3 | $0.00 | 2,750 | $0 | 0.0% |
| Total | $19.42 avg | 18,902 | $367K | 100% |
| Filing → |
| TXG | SELL | 2026-08-26 | $1.2M | — | Filing → |
| TXG | SELL | 2026-06-24 | $1.0M | — | Filing → |
| TXG | SELL | 2026-05-27 | $709K | — | Filing → |